1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    












































































































    Intra-Arterial Chemotherapy as a Treatment for Intraocular Retinoblastoma: Alternatives to Direct Ophthalmic Artery Catheterization | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      



          


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleHead & Neck

  
      

  
      
Intra-Arterial Chemotherapy as a Treatment for Intraocular Retinoblastoma: Alternatives to Direct Ophthalmic Artery Catheterization
  
    	
M.A. Klufas, Y.P. Gobin, B. Marr, S.E. Brodie, I.J. Dunkel and D.H. Abramson

  
    	
American Journal of Neuroradiology September 2012,  33 (8) 1608-1614; DOI: https://doi.org/10.3174/ajnr.A3019 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵


    1. Abramson  DH, 
    2. Dunkel  IJ, 
    3. Brodie  SE, 
    4. et al
    .
A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
Ophthalmology
2008;
115:
1398–
404, 
1404.e1. Epub 2008 Mar 14.

    CrossRefPubMedWeb of Science
    

  2. 2.↵


    1. Abramson  DH, 
    2. Dunkel  IJ, 
    3. Brodie  SE, 
    4. et al
    .
Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy.
Arch Ophthalmol
2010;
128:
370–
72

    CrossRefPubMedWeb of Science
    

  3. 3.↵


    1. Abramson  DH, 
    2. Dunkel  IJ, 
    3. Brodie  SE, 
    4. et al
    .
Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
Ophthalmology
2010;
117:
1623–
29. 
Epub 2010 Apr 9

    CrossRefPubMedWeb of Science
    

  4. 4.↵


    1. Abramson  DH
    .
Super selective ophthalmic artery delivery of chemotherapy for intraocular retinoblastoma: ‘chemosurgery' the first Stallard lecture.
Br J Ophthalmol
2010;
94:
396–
99

    FREE Full Text
    

  5. 5.↵


    1. Gobin  YP, 
    2. Dunkel  IJ, 
    3. Marr  BP, 
    4. et al
    .
Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.
Arch Ophthalmol
2011;
129:
732–
37

    CrossRefPubMedWeb of Science
    

  6. 6.↵


    1. Reese  AB, 
    2. Hyman  GA, 
    3. Merriam  GR  Jr., 
    4. et al
    .
Treatment of retinoblastoma by radiation and triethylenemelamine.
AMA Arch Ophthalmol
1954;
53:
505–
13

    PubMedWeb of Science
    

  7. 7.↵


    1. Hyman  GA, 
    2. Reese  AB
    .
Combination therapy of retinoblastoma with triethylene melamine and radiotherapy.
J Am Med Assoc
1956;
162:
1368–
73

    CrossRefPubMed
    

  8. 8.↵


    1. Hayreh  SS
    .
Orbital vascular anatomy.
Eye (Lond)
2006;
20:
1130–
44

    CrossRefPubMed
    

  9. 9.↵


    1. Yamane  T, 
    2. Kaneko  A, 
    3. Mohri  M
    .
The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma.
Int J Clin Oncol
2004;
9:
69–
73

    CrossRefPubMed
    

  10. 10.↵


    1. Gobin  YP, 
    2. Cloughesy  TF, 
    3. Chow  KL, 
    4. et al
    .
Intra-arterial chemotherapy for brain tumors by using a spatial dose fractionation algorithm and pulsatile delivery.
Radiology
2001;
218:
724–
32

    PubMedWeb of Science
    

  11. 11.↵


    1. Brodie  SE, 
    2. Gobin  YP, 
    3. Dunkel  IJ, 
    4. et al
    .
Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma.
Doc Ophthalmol
2009;
119:
13–
22

    CrossRefPubMedWeb of Science
    

  12. 12.↵


    1. Marr  B, 
    2. Gobin  PY, 
    3. Dunkel  IJ, 
    4. et al
    .
Spontaneously resolving periocular erythema and ciliary madarosis following intra-arterial chemotherapy for retinoblastoma.
Middle East Afr J Ophthalmol
2010;
17:
207–
09

    CrossRefPubMed
    

  13. 13.↵


    1. Vajzovic  LM, 
    2. Murray  TG, 
    3. Aziz-Sultan  MA, 
    4. et al
    .
Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastoma.
Clin Ophthalmol
2011;
5:
171–
76. 
Epub 2011 Feb 10

    PubMed
    

  14. 14.↵


    1. Cooke  D, 
    2. Farid  H, 
    3. Kim  W, 
    4. et al
    .
Zygomatico-orbital intra-arterial melphalan infusion for intraocular retinoblastoma.
J Neurointerv Surg
2012;
4:
e16

    Abstract/FREE Full Text
    

  15. 15.↵


    1. Pham  CT, 
    2. Blanc  R, 
    3. Rouic  LL, 
    4. et al
    .
Access to the ophthalmic artery by retrograde approach through the posterior communicating artery for intra-arterial chemotherapy of retinoblastoma.
Neuroradiology 
2011
Nov
18.
[Epub ahead of print]

    

  16. 16.↵


    1. Kiribuchi  M, 
    2. Hasegawa  H
    .
Retrograde infusion of anti-cancer drugs to the ophthalmic artery for intra ocular malignant tumors [in Japanese].
Iryo
1968;
22:
772–
76

    PubMed
    

  17. 17.↵


    1. Hayreh  SS, 
    2. Dass  R
    .
The ophthalmic artery. I. Origin and intra-cranial and intra-canalicular course.
Br J Ophthalmol
1962;
46:
65–
98

    FREE Full Text
    

  18. 18.↵


    1. Benz  MS, 
    2. Scott  IU, 
    3. Murray  TG, 
    4. et al
    .
Complications of systemic chemotherapy as treatment of retinoblastoma.
Arch Ophthalmol
2000;
118:
577–
78

    PubMedWeb of Science
    

  19. 19.↵


    1. Abramson  DH, 
    2. Beaverson  KL, 
    3. Chang  ST, 
    4. et al
    .
Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth group Vb retinoblastoma.
Arch Ophthalmol
2004;
122:
1316–
23

    CrossRefPubMedWeb of Science
    

  20. 20.↵


    1. Abramson  DH, 
    2. Melson  MR, 
    3. Dunkel  IJ, 
    4. et al
    .
Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma.
Ophthalmology
2001;
108:
1868–
76

    CrossRefPubMedWeb of Science
    

  21. 21.↵


    1. Wong  FL, 
    2. Boice  JD  Jr., 
    3. Abramson  DH, 
    4. et al
    .
Cancer incidence after retinoblastoma: radiation dose and sarcoma risk.
JAMA
1997;
278:
1262–
67

    CrossRefPubMedWeb of Science
    

  22. 22.↵


    1. Murphree  AL, 
    2. Villablanca  JG, 
    3. Deegan  WF  3rd., 
    4. et al
    .
Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
Arch Ophthalmol
1996;
114:
1348–
56

    CrossRefPubMedWeb of Science
    

  23. 23.↵


    1. Friedman  DL, 
    2. Himelstein  B, 
    3. Shields  CL, 
    4. et al
    .
Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
J Clin Oncol
2000;
18:
12–
17

    Abstract/FREE Full Text
    

  24. 24.↵


    1. Shields  CL, 
    2. Honavar  SG, 
    3. Meadows  AT, 
    4. et al
    .
Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Am J Ophthalmol
2002;
133:
657–
64

    CrossRefPubMedWeb of Science
    

  25. 25.↵


    1. Rizzuti  AE, 
    2. Dunkel  IJ, 
    3. Abramson  DH
    .
The adverse events of chemotherapy for retinoblastoma: what are they? Do we know?
Arch Ophthalmol
2008;
126:
862–
65

    CrossRefPubMedWeb of Science
    

  26. 26.↵


    1. Jehanne  M, 
    2. Lumbroso-Le Rouic   L, 
    3. Savignoni  A, 
    4. et al
    .
Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma.
Pediatr Blood Cancer
2009;
52:
637–
43

    CrossRefPubMedWeb of Science
    

  27. 27.↵


    1. Gombos  DS, 
    2. Hungerford  J, 
    3. Abramson  DH, 
    4. et al
    .
Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor?
Ophthalmology
2007;
114:
1378–
83

    CrossRefPubMedWeb of Science
    

  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Intra-Arterial Chemotherapy as a Treatment for Intraocular Retinoblastoma: Alternatives to Direct Ophthalmic Artery Catheterization
  
    	
M.A. Klufas, Y.P. Gobin, B. Marr, S.E. Brodie, I.J. Dunkel, D.H. Abramson

  
    	
American Journal of Neuroradiology Sep 2012, 33 (8) 1608-1614; DOI: 10.3174/ajnr.A3019 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    

  

    
 Related Articles
  • No related articles found.
 Cited By...
 More in this TOC Section
 Similar Articles

  



  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement